NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/28/2026
Back to search
Official data from USPTO
HELIXMITH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HELIXMITH
ST13
US500000088166343Class
5, 35, 42
Filing
88166343
Registration
5906698
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
08/17/2026
Trademark type
Word
Nice classes
5, 35, 42
Filing date
10/23/2018
Registration date
11/12/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/28/2026
Last transaction
08/17/2026
Responsible office
United States Patent and Trademark Office
Status code
705
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
Seoul, KR
Examiner
MAI, TINA HSIN
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Helixmith Co., Ltd
ViroMed Co., Ltd.
Representatives
Connie L. Ellerbach Fenwick & West LLP
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; medicines for human purposesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; therapeutic drugs and agentsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; crude medicinesfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparationsfor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer; biological preparations for medical usefor treating neurological diseasemuscular diseaseischemic diseaserenal diseasecancer
Class 35
Retail store services featuring reagents for use in veterinary genetic testing; retail store services featuring chemical preparations for pharmaceutical purposes; retail store services featuring chemical preparations for use in DNA analysis for medical use; retail store services featuring drugs for medical purposes; retail store services featuring reagents for use in medical genetic testing; retail store services featuring pharmaceutical preparations for diagnosis; retail store services featuring pharmaceutical preparations for the treatment of immune system related diseases and disorders; retail store services featuring ethical medicinal preparations; retail store services featuring therapeutic drugs and agentsretail store services featuring biological preparations for medical use
Class 42
Research and development of vaccines and medicines; providing information relating to scientific analysis of the genetic information via online networks; scientific research in the fields of biomedicine; biological information analysisgenetic testing for medical research purposes; biological information analysisgenetic testing for scientific research purposes; research and testing services in the fields of bacteriology and virology; drug discovery services; research and development in the pharmaceutical and biotechnology fields; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; consultancy relating to the pharmaceutical research and development; pharmaceutical research and development; pharmaceutical research services; laboratory research in the field of gene expression; gene analysis for research; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine/health and pharmacology; analysis of human serum for medical research ; analysis of human tissues for medical research; blood analysis services
Publications
History of USPTO decisions and trademark events.
44 publications found
C15P
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/28/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/27/2026
E815
TEAS SECTION 8 & 15 RECEIVED
04/24/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/12/2024
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
08/25/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
08/10/2020
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
02/19/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/18/2020
XXXX
POST REGISTRATION ACTION CORRECTION
02/18/2020
WDRL
OTQR WITHDRAWAL FROM PUBLICATION
02/18/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
01/21/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/21/2020
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/03/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/12/2019
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
10/06/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/19/2019
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
06/11/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/28/2019
PUBO
PUBLISHED FOR OPPOSITION
05/28/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/08/2019
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
04/22/2019
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
04/03/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/03/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
04/03/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/29/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/22/2019
GNRT
NON-FINAL ACTION E-MAILED
03/22/2019
CNRT
NON-FINAL ACTION WRITTEN
03/22/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2019
ALIE
ASSIGNED TO LIE
03/08/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/05/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/05/2019
GNRT
NON-FINAL ACTION E-MAILED
01/05/2019
CNRT
NON-FINAL ACTION WRITTEN
01/05/2019
DOCK
ASSIGNED TO EXAMINER
01/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/05/2018
NWAP
NEW APPLICATION ENTERED
10/26/2018
Continuous trademark protection
Get notified about every new filing that threatens HELIXMITH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.